All Relations between Schizophrenia and Clozapine

Publication Sentence Publish Date Extraction Date Species
Javeria Sahib Din, Ernesto Navarro Garcia, Hiba Al-Rubaye, Carlos Julia. Knee Buckling as an Atypical Adverse Effect of Clozapine: A Case Report. Cureus. vol 16. issue 3. 2024-04-10. PMID:38595866. clozapine has become a widely popular and effective medication in the treatment of refractory schizophrenia and refractory bipolar disorder. 2024-04-10 2024-04-12 Not clear
Nuree Kang, Hee-Soo Yoon, Se Hyun Kim, Jae Hoon Jeong, Minah Kim, Jun Soo Kwo. Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study. Psychiatry investigation. vol 21. issue 3. 2024-04-03. PMID:38569589. comparative study of the efficacy and side effects of brand-name and generic clozapine for long-term maintenance treatment among korean patients with schizophrenia: a retrospective naturalistic mirror-image study. 2024-04-03 2024-04-06 Not clear
Nuree Kang, Hee-Soo Yoon, Se Hyun Kim, Jae Hoon Jeong, Minah Kim, Jun Soo Kwo. Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study. Psychiatry investigation. vol 21. issue 3. 2024-04-03. PMID:38569589. clozapine is considered the most reliable drug for treatment-resistant schizophrenia. 2024-04-03 2024-04-06 Not clear
Nuree Kang, Hee-Soo Yoon, Se Hyun Kim, Jae Hoon Jeong, Minah Kim, Jun Soo Kwo. Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study. Psychiatry investigation. vol 21. issue 3. 2024-04-03. PMID:38569589. this study was performed to provide clinical information regarding the use of clozapine and to compare efficacy and tolerability when converting from the brand-name formulation (clozaril) to the generic formulation during longterm maintenance treatment among korean patients with schizophrenia. 2024-04-03 2024-04-06 Not clear
Jingqi He, Jinguang Li, Yisen Wei, Zhangyin He, Junyu Liu, Ning Yuan, Risheng Zhou, Xingtao He, Honghong Ren, Lin Gu, Yanhui Liao, Xiaogang Chen, Jinsong Tan. Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia. BMC psychiatry. vol 24. issue 1. 2024-04-02. PMID:38566016. glutamatergic function abnormalities have been implicated in the etiology of treatment-resistant schizophrenia (trs), and the efficacy of clozapine may be attributed to its impact on the glutamate system. 2024-04-02 2024-04-05 Not clear
Justina A Warnick, Rachel I Gifeisman, Khevna P Joshi, Sophie A Roe, Rick A Hiciano, Christopher P Conroy, Sohrab Zahed. Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature. Journal of correctional health care : the official journal of the National Commission on Correctional Health Care. 2024-04-02. PMID:38563618. in the correctional setting, patients with severe and persistent schizophrenia are frequently nonadherent due to lack of insight and anemic access to health care resources, specifically as these pertain to clozapine. 2024-04-02 2024-04-04 Not clear
Yuichi Uwai, Tomohiro Nabekur. Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database. Drugs - real world outcomes. 2024-03-31. PMID:38556566. clozapine shows higher efficacy against treatment-resistant schizophrenia than other antipsychotics. 2024-03-31 2024-04-03 Not clear
Estela Sangüesa, Emilio Fernández-Egea, Julia Concha, Cristina B García, María Pilar Ribat. Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia. Biomedicines. vol 12. issue 3. 2024-03-28. PMID:38540209. impact of pharmacogenetic testing on clozapine treatment efficacy in patients with treatment-resistant schizophrenia. 2024-03-28 2024-03-30 Not clear
Estela Sangüesa, Emilio Fernández-Egea, Julia Concha, Cristina B García, María Pilar Ribat. Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia. Biomedicines. vol 12. issue 3. 2024-03-28. PMID:38540209. managing schizophrenia with clozapine poses a significant challenge due to prevalent therapeutic failures. 2024-03-28 2024-03-30 Not clear
Natasha Marcella Vaselli, Stanley Du Preez, Nuwan Jasenthu Kankanamag. Clozapine-induced pneumonitis mimicking an atypical pneumonia. BMJ case reports. vol 17. issue 3. 2024-03-26. PMID:38531554. clozapine is an antipsychotic used for treatment-resistant schizophrenia with a significant side effect profile, including agranulocytosis, myocarditis and fever. 2024-03-26 2024-03-29 Not clear
Reza Rafizadeh, Anmol Sooch, Alessia Risi, Nicoline Bihelek, Kyler Kanegawa, Alasdair M Barr, Randall F White, Christian G Schütz, Chad A Bousma. Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder. Journal of psychopharmacology (Oxford, England). 2024-03-23. PMID:38520287. impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder. 2024-03-23 2024-03-26 Not clear
Spenser Barry, L Fredrik Jarskog, Kai Xia, Rohit Simha Torpunuri, Xiaoyu Wu, Xiaoming Zen. Racial Disparities in Clozapine Prescription Patterns Among Patients With Schizophrenia. Psychiatric services (Washington, D.C.). 2024-03-19. PMID:38500451. racial disparities in clozapine prescription patterns among patients with schizophrenia. 2024-03-19 2024-03-21 Not clear
Spenser Barry, L Fredrik Jarskog, Kai Xia, Rohit Simha Torpunuri, Xiaoyu Wu, Xiaoming Zen. Racial Disparities in Clozapine Prescription Patterns Among Patients With Schizophrenia. Psychiatric services (Washington, D.C.). 2024-03-19. PMID:38500451. previous research has suggested that demographic factors affect the likelihood of a patient with schizophrenia receiving a clozapine prescription. 2024-03-19 2024-03-21 Not clear
Felipe Mendonça Rocha Barros, Arthur Cardoso Tolentino, Lais Soares Ker Marques, Leandro Xavier de Camargo Schlittler, Karina Diniz Oliveira, Paulo Dalgalarrondo, Lucas Luchesi Barnes, Amilton Dos Santos Junior, Claudio Eduardo Muller Banzat. Successful Clozapine Rechallenge After Clozapine-Induced Severe Anemia: A Case Report. Schizophrenia bulletin. 2024-03-19. PMID:38502910. clozapine, a second-generation antipsychotic (sga), is considered the gold standard medication to treat patients with treatment-resistant schizophrenia (trs). 2024-03-19 2024-03-23 Not clear
Natalia Mansur Haddad, Leonardo Peroni De Jesus, Mauricio Serpa, Martinus Van De Bilt, Leda Talib, Alana Costa, Wagner Gattaz, Alexandre Andrade Loc. Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication. European archives of psychiatry and clinical neuroscience. 2024-03-19. PMID:38502208. a final sample of 93 individuals was divided into 3 groups: patients with schizophrenia using clozapine (treatment-resistant) (n = 29), patients with schizophrenia using another antipsychotic (n = 31), and controls (n = 33). 2024-03-19 2024-03-23 Not clear
Natalia Mansur Haddad, Leonardo Peroni De Jesus, Mauricio Serpa, Martinus Van De Bilt, Leda Talib, Alana Costa, Wagner Gattaz, Alexandre Andrade Loc. Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication. European archives of psychiatry and clinical neuroscience. 2024-03-19. PMID:38502208. regarding the cb2 receptor, the values of patients with schizophrenia and controls were similar, but those of patients using antipsychotics other than clozapine differed (p = 0.022). 2024-03-19 2024-03-23 Not clear
Christoph U Correll, Celso Arango, Birgitte Fagerlund, Silvana Galderisi, Martien J Kas, Stefan Leuch. Identification and treatment of individuals with childhood-onset and early-onset schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 82. 2024-03-16. PMID:38492329. since early age of illness onset is a consistent risk factor for treatment-resistant schizophrenia (trs), clinicians need to be competent in diagnosing trs and using clozapine. 2024-03-16 2024-03-19 Not clear
Massimo Berneri, Uma Jha, Seán O'Halloran, Sam Salman, Shanek Wickramasinghe, Kevin Kendrick, Jessica Nguyen, David A Joyc. Validation of Population Pharmacokinetic Models for Clozapine Dosage Prediction. Therapeutic drug monitoring. 2024-03-06. PMID:38446630. clozapine is unique in its capacity to ameliorate severe schizophrenia but at high risk of toxicity. 2024-03-06 2024-03-09 Not clear
Mark Ainsley Colij. Clozapine Use in 22q11.2 Deletion Syndrome: A Systematic Review of the Literature. Journal of clinical psychopharmacology. 2024-02-26. PMID:38407281. while current recommendations regarding the management of psychotic symptoms in affected individuals are generally in keeping with treatment guidelines for general schizophrenia populations, evidence for the use of clozapine has come from case reports and retrospective observational data. 2024-02-26 2024-02-28 Not clear
Yuki Kikuchi, Hiroshi Komatsu, Yuji Otsuka, Fumiaki Ito, Yuji Yada, Hiroaki Tanifuji, Hiroaki Tomit. Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia. Psychiatry research. vol 334. 2024-02-21. PMID:38382186. effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among japanese patients with schizophrenia. 2024-02-21 2024-02-24 Not clear